CAR T-cell Therapy Has Some Patients Crowdfunding to Cover Costs

Posted September 17, 2019

External Article: Healio

Aaron Levine, an associate professor in the Georgia Institute of Technology School of Public Policy, was recently quoted in an article entitled “CAR T-cell Therapy has Some Patients Crowdfunding to Cover Costs” for Healio, September 13.

Here's an excerpt:

Levine said the purpose of the perspective was to raise awareness among researchers and clinicians of the financial challenges facing patients who pursue CAR T-cell therapy.

“Clinicians need to be aware that this therapy, while promising, is forcing at least a subset of patients to turn to an alternate source of funding, and that they really ought to think about the economics and how they talk to their patients about this,” he said.

Read the full story here.

The School of Public Policy is a unit of the Ivan Allen College of Liberal Arts.